Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytoplasmic dynein 2 intermediate chain 1 (DYNC2I1, also known as WDR60) is a non-catalytic, WD repeat-containing accessory protein that forms part of the cytoplasmic dynein-2 complex—a multisubunit motor protein responsible for retrograde cargo transport within cilia and flagella, in conjunction with the intraflagellar transport (IFT) system[1][2][4][5][6][7]. DYNC2I1 interacts with the heavy chain (DYNC2H1/DHC2) and another intermediate chain (WDR34) to mediate cargo movement toward the ciliary base, assuring proper ciliary assembly, signaling, and maintenance. Defects in this protein disrupt ciliary function, causing various ciliopathies—genetic disorders affecting the skeleton and other organs. DYNC2I1’s essential cellular roles include cell cycle regulation, signal transduction, and programmed cell death, highlighting its broad importance beyond ciliary biology[2][4][5][6]. **Notes:** - No drugs are currently known to directly target DYNC2I1. - While pathogenic mutations are clinically relevant (underlying role in genetic syndromes), this protein is not currently considered a drug target (therapeutic target) in the sense of receptors, enzymes, or classic drug modulators. - DYNC2I1 is often referred to interchangeably with "WDR60" in structural and genetic literature[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytoplasmic dynein 2 intermediate chain 1 (DYNC2I1).